HLA
TELA icon

Hamilton Lane Advisors’s TELA Bio TELA Stock Holding History

Hamilton Lane Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,277
Closed -$475K – 71
2022
Q4 		$475K Hold
41,277
– – 0.17% 49
2022
Q3 		$352K Sell
41,277
-223,089
-84% -$1.85M 0.13% 49
2022
Q2 		$1.85M Buy
+264,366
New +$2.2M 0.72% 20

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Hamilton Lane Advisors's TELA Position: Q1 2023 in Review

Hamilton Lane Advisors sold out of TELA Bio (TELA) in Q1 2023, closing a stake of 41,277 shares — an estimated $475K sold.

Hamilton Lane Advisors first reported a position in TELA in Q2 2022 and held it in 3 quarters. The position peaked at $1.85M in Q2 2022. 53 funds tracked by Wall St. Rank hold TELA as of Q1 2023.

  • Hamilton Lane Advisors reported no remaining TELA Bio position as of Q1 2023 after selling out during the quarter.
  • Hamilton Lane Advisors sold 41,277 TELA Bio shares in Q1 2023, an estimated $475K.
  • Hamilton Lane Advisors first reported a position in TELA Bio in Q2 2022 and held it in 3 quarters.
  • Hamilton Lane Advisors's TELA Bio position peaked at $1.85M in Q2 2022.
  • 53 funds tracked by Wall St. Rank held TELA Bio as of Q1 2023.

Based on Hamilton Lane Advisors's 13F filing for Q1 2023, filed 2 May 2023.